Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service

    Nov 8, 2022, 09:56 AM by
    Full story
  • RCH Solutions To Present at 20/15 Visioneers’ Virtual Cloud Lab, HTE and Lab Automation Conference

    Nov 8, 2022, 09:52 AM by
    Leading a talk on Next Generation Compute Environments, the long-time provider of computing consulting and execution services exclusively to R&D teams in the Life Sciences will take the virtual stage on November 8, 2022.
    Full story
  • Comparing Open Source Research Data Management Tools

    Nov 8, 2022, 01:00 AM by User Not Found
    Bio-IT World | At the Bio-IT World Conference and Expo, Europe, event in Berlin last month, Eelke van der Horst of The Hyve compared various open source research data management tools including The Hyve’s new offering: Fairspace.
    Full story
  • Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D

    Nov 7, 2022, 10:28 AM by
    BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.
    Full story
  • Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place

    Nov 7, 2022, 10:26 AM by
    The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.
    Full story
  • New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference

    Nov 7, 2022, 10:26 AM by
    A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.
    Full story
  • CD ComputaBio Introduces Four Docking Software for Drug Development

    Nov 4, 2022, 11:12 AM by
    Full story
  • Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions

    Nov 4, 2022, 11:12 AM by
    Full story
  • Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services

    Nov 4, 2022, 10:59 AM by
    Full story
  • Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service

    Nov 4, 2022, 10:58 AM by
    Full story
  • Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response

    Nov 4, 2022, 10:55 AM by
    I wanted to share the Vermont Department of Health and VisualDx just launched the Clinician Support Initiative to help healthcare professionals respond to emergent infectious disease outbreaks, like Monkeypox, Covid, and Polio, by leveraging assistive technology. Given the challenge of identifying and treating rare diseases amid ongoing staffing and burnout issues, Vermont is offering all clinicians in the state free access to VisualDx’s diagnostic support platform. The tool contains clinical information, medical reference images, and real-time reporting, all of which are critical for patient care and public health response.
    Full story
  • medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

    Nov 4, 2022, 10:53 AM by
    medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials. Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
    Full story
  • Jumo Health Honored in Inc.’s Inaugural Power Partner Awards

    Nov 3, 2022, 10:59 AM by
    Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.
    Full story
  • Mayo Clinic, Orbita to Speak on Successful Utilization of Intelligent Virtual Assistants at HCIC

    Nov 3, 2022, 10:58 AM by
    Full story
  • People, Like Worms, May Have Distinct Biological Ages

    Nov 3, 2022, 01:00 AM by User Not Found
    Bio-IT World | The timing of age-associated vigorous movement cessation is highly correlated with lifespan across populations, but the reason may be some unknown upstream factor that throws into question the way biomarkers are sometimes used to track the benefits of anti-aging therapies. At least that’s what is suggested by a new study using a “Lifespan Machine” to follow the life and death of tens of thousands of nematodes.
    Full story
  • Vaxess Announces $27M in Series B Funding

    Nov 2, 2022, 10:15 AM by
    Vaxess Technologies, Inc., a life sciences company developing a shelf-stable, sustained-release vaccine patch, today announced the closing of its Series B funding.
    Full story
  • Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits

    Nov 2, 2022, 10:15 AM by
    Full story
  • Creative Enzymes Expands Its Probiotic Portfolio

    Nov 2, 2022, 10:14 AM by
    Full story
  • BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

    Nov 2, 2022, 10:11 AM by
    BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.
    Full story
  • BOC Sciences Makes Easy Access to Polymerization Tech

    Nov 2, 2022, 10:11 AM by
    Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.
    Full story
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107 (current)
  • 108
  • 109
  • 110
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy